References
- Nelson DS. Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts. Transplant Rev 1974;19:226–254.
- Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 1998;339:1506–1514.
- Oki Y, Yamamoto K, Kato H, et al Low absolute lymphocyte count is a poor prognostic marker in patients with diffuse large B-cell lymphoma and suggests patients' survival benefit from rituximab. Eur J Haematol 2008;81:448–453.
- Porrata LF, Rsitow K, Inwards DJ, et al Lymphopenia assessed during routine follow-up after immunochemotherapy (R-CHOP) is a risk factor for predicting relapse in patients with diffuse large B-cell lymphoma. Leukemia 2010;24:1343–1349.
- Claude L, Perol D, Ray-Coquard I, et al Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Radiother Oncol 2005;76:334–339.
- Ray-Coquard I, Cropet C, Van Glabbeke M, et al Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas. Cancer Res 2009;69:5383–5391.
- Lossos IS, Wiernik PH, Justice G, et al Lenalidomide response in relapsed/refractory diffuse large B-cell non-Hodgkin lymphoma. Blood 2007;110(Suppl. 1): Abstract 2564.
- Castillo JJ, Morales D, Quinones P, Cotrina E, Desposorio C, Beltran B. Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified. Leuk Lymphoma 2010;51>:1822–1828.
- Ray-Coquard I, Borg C, Bachelot T, et al Baseline and early lymphopenia predict for the risk of febrile neutropenia after chemotherapy. Br J Cancer 2003;88:181–186.
- Borg C, Ray-Coquard I, Philip I, et al CD4 lymphopenia as a risk factor for febrile neutropenia and early death after cytotoxic chemotherapy in adult patients with cancer. Cancer 2004;101:2675–2680.
- Dworacki G, Meidenbauer N, Kuss I, et al Decreased zeta chain expression and apoptosis in CD3+ peripheral blood T lymphocytes of patients with melanoma. Clin Cancer Res 2001;7:947s–957s.
- Saito T, Kuss I, Dworacki G, Gooding W, Johnson JT, Whiteside TL. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer. Clin Cancer Res 1999;5:1263–1273.
- Plonquet A, Haioun C, Jais JP, et al Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol 2007;18:1209–1215.